The importance of genetic and nutritional factors in responses to vitamin D and its analogs in osteoporotic patients
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Calcified Tissue International
- Vol. 60 (1) , 119-123
- https://doi.org/10.1007/s002239900199
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of 1?-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosisCalcified Tissue International, 1994
- The ultra long-term treatment of senile osteoporosis with 1α-hydroxyvitamin D3Bone and Mineral, 1993
- Vitamin D3and Calcium to Prevent Hip Fractures in Elderly WomenNew England Journal of Medicine, 1992
- Treatment of Postmenopausal Osteoporosis with High Doses of Synthetic CalcitriolAnnals of Internal Medicine, 1990
- Calcitriol Treatment Is Not Effective in Postmenopausal OsteoporosisAnnals of Internal Medicine, 1989
- Genetic determinants of bone mass in adults. A twin study.Journal of Clinical Investigation, 1987
- Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.Journal of Clinical Investigation, 1984
- Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic PatientsNew England Journal of Medicine, 1981
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- Genetic Factors in Determining Bone MassJournal of Clinical Investigation, 1973